Inspire Medical Systems, Inc. INSP

MINNEAPOLIS, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea (OSA), today announced that the American Medical Association (AMA) CPT® Editorial Panel has approved the establishment of a new set of Current Procedural Terminology (CPT®) codes that accurately describe and include the Inspire V syste

Inspire Medical Systems has seen its share price fall sharply over several years, and that slide raises a pointed question about whether the current market value still lines up with the cash the business is expected to generate. With the stock now well below past peaks, the key issue is how today’s US$69.36 price compares with its future cash flow profile. The share price decline of 71.2% over 5 years puts long term expectations for Inspire Medical Systems’ cash generation under the...

Inspire Medical Systems (INSP) has been drawing attention after a sharp move in its share price, with the stock last closing at US$70. That shift is prompting fresh questions about how investors are treating this sleep apnea specialist. Recent trading tells a mixed story for Inspire Medical Systems. The share price has surged with a 56.9% 90 day return and 13.9% 1 month gain; yet momentum is fading near term with the 7 day share price return down 7.6% and the year to date share price return...

Stryker's sales have grown about 10% a year on average over the past three years, and so have ResMed's. That shared growth rate in medical devices is the bet the two have in common. Stryker (SYK) is the giant, selling hospitals everything from hip and knee products to capital equipment. ResMed is a sleep device maker with less than a quarter of Stryker's revenue. Stryker costs 32.6 times its past year's earnings, against 21.9 times for ResMed. So does Stryker's reach justify that higher price? T

Exciting developments are taking place for the stocks in this article. They’ve all surged ahead of the broader market over the last month as catalysts such as new products and positive media coverage have propelled their returns.

Inspire Medical Systems has seen its share price move sharply over several timeframes, which naturally puts the focus on whether the current valuation is supported by the cash it can generate. With the stock price at US$74.32 at the last close, the key issue now is how that market tag lines up with the business’s future cash flows. Over the past 5 years, Inspire Medical Systems shares have fallen 70.2%, which puts a lot of weight on whether the underlying cash flow story still backs the...

Shares of medical technology company Inspire Medical Systems (NYSE:INSP) jumped 7.4% in the morning session after Stifel analyst Jonathan Block raised the price target on the company to $80.00 from $75.00 while maintaining a Buy rating.

Inspire Medical Systems currently trades at $62.14 per share and has shown little upside over the past six months, posting a small loss of 3.4%. The stock also fell short of the S&P 500’s 11.7% gain during that period.